Back to NORTHERN TRUST CORP NORTHERN TRUST CORP

CGEMCGEM
Showing 8 of 22 quarters

Position history for NORTHERN TRUST CORPNORTHERN TRUST CORP's holdings in CULLINAN THERAPEUTICS INC

NORTHERN TRUST CORP holds 571,080 shares of CGEM (CULLINAN THERAPEUTICS INC), worth $10.4M as of 2026-Q2. The position was increased (+27.1% shares). CGEM represents 0.0% of NORTHERN TRUST CORP's portfolio.

Current Value

$10.4M

Current Shares

571,080

Total Value Change

+$2.5M

Total Shares Change

+100,195

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
571,080
+27.1%
$10.4M0.0%$18.21
34
2026-Q1
Increased
449,258
+6.5%
$6.4M0.0%$15.73
29
2025-Q4
Decreased
421,635
-5.7%
$4.4M0.0%$9.92
0
2025-Q3
Decreased
447,267
-1.3%
$2.7M0.0%$5.97
0
2025-Q2
Decreased
453,203
-6.3%
$3.4M0.0%$7.76
0
2025-Q1
Decreased
483,889
-3.4%
$3.7M0.0%$8.02
0
2024-Q4
Increased
500,908
+6.4%
$6.1M0.0%$12.20
29
2024-Q3
Increased
470,885
+58.6%
$7.9M0.0%$17.19
39

Other major holders of CGEM: BlackRock, Inc., BAUPOST GROUP LLC/MA, STATE STREET CORP, BlackRock Finance, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used